REBECCA SAPP: Open Payments
NPI 1255814752 · VANCEBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 51 payments from 14 companies in 2025. Trend: 2023 $1,282 · 2024 $1,457 · 2025 $993
Food & beverage: $993
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $244 |
| AstraZeneca Pharmaceuticals LP | 7 | $157 |
| Novo Nordisk Inc | 6 | $139 |
| Otsuka America Pharmaceutical, Inc. | 5 | $79 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| Phathom Pharmaceuticals, Inc. | 3 | $52 |
| Lilly USA, LLC | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
Products named: UBRELVY, REXULTI, BREZTRI, Auvelity, FARXIGA, Ozempic, VOQUEZNA, Rybelsus.
Industry payments across KY — which companies pay providers there.
